| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JQ-1 | CTRPv2 | pan-cancer | AAC | -0.0068 | 0.8 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.0095 | 0.8 |
| mRNA | AA-COCF3 | CTRPv2 | pan-cancer | AAC | 0.0074 | 0.8 |
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | -0.0095 | 0.8 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | 0.0076 | 0.8 |
| mRNA | simvastatin | CTRPv2 | pan-cancer | AAC | 0.0078 | 0.8 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | 0.0069 | 0.8 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.0055 | 0.8 |